Ken Griffin Night Hawk Biosciences, Inc. Call Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$0.26 - $0.51 $624 - $1,224	-2,400 Reduced 1.93%	121,900 $53,000
Q3 2023 Nov 14, 2023	BUY	$0.5 - $0.72 $900 - $1,296	1,800 Added 1.47%	124,300 $65,000
Q2 2023 Aug 14, 2023	SELL	$0.62 - $0.87 $1,674 - $2,349	-2,700 Reduced 2.16%	122,500 $82,000
Q1 2023 May 15, 2023	SELL	$0.83 - $1.24 $19,090 - $28,520	-23,000 Reduced 15.52%	125,200 $108,000
Q4 2022 Feb 14, 2023	BUY	$0.77 - $1.62 $8,008 - $16,848	10,400 Added 7.55%	148,200 $120,000
Q3 2022 Nov 14, 2022	SELL	$1.79 - $2.96 $1,253 - $2,072	-700 Reduced 0.51%	137,800 $238,000

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.